Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S. Food and Drug Administration has ...

According to the company, enVista Envy IOLs will be commercially available in the U.S. on a limited basis in the coming weeks ...

Bausch + Lomb Corporation , a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S. Food and Drug Administration has approved the ...

The FDA granted approval to the enVista Envy full range of vision IOLs following Canadian approval in May 2024.

A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.The global Intraocular Lens (IOL) market ...

Cataracts, a common eye condition that clouds vision and hampers daily activities, can now be treated with innovative ...

Toric IOLs enable a lens-based surgical approach to the treatment of astigmatism. Although the lens may cause some of the eye's astigmatism, this is removed at the time of cataract surgery ...

The fixed variables were the sample of eyes with preoperative keratometry data, the presumed surgically induced astigmatism for use in the Acrysof ® Toric ® IOL calculator and the selection ...

Cataract surgery is a life-changing procedure that can restore clear vision and improve the quality of life. One needs to be ...

Eyebright Medical Technology (Beijing) Co., Ltd. ("Eyebright Medical", the "Company", Stock Code: 688050.SH, together with its subsidiaries collectively known as the "Group") is pleased to announce ...